Reference Measurement Procedures for Alzheimer’s Disease Cerebrospinal Fluid Biomarkers: Definitions and Approaches With Focus on Amyloid β42
Year: 2012
Type: article
Source: Biomarkers in Medicine
DOI: 10.2217/bmm.12.39
Authors: Niklas Mattsson, Ingrid Zegers, Ulf Andreasson, Maria Bjerke, Marinus A Blankenstein, Robert Bowser, Maria C Carrillo, Johan Gobom, Theresa Heath, Rand Jenkins, Andreas Jeromin, June Kaplow, Daniel Kidd, Omar F Laterza, Andrew Lockhart, Michael P Lunn, Robert L Martone, Kevin Mills, Josef Pannee, Marianne Ratcliffe, Leslie M Shaw, Adam J Simon, Holly Soares, Charlotte E Teunissen, Marcel M Verbeek, Robert M Umek, Hugo Vanderstichele, Henrik Zetterberg, Kaj Blennow, Erik Portelius
Institutions: Sahlgrenska University Hospital, National Hospital for Neurology and Neurosurgery, UCL Queen Square Institute of Neurology, University College London, University of Gothenburg, European Commission, Joint Research Center, Joint Research Centre, Joint Research Centre, Amsterdam UMC Location Vrije Universiteit Amsterdam, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Alzheimer's Association, Banyan Biomarkers (United States), Eisai (United States), Janssen Alzheimer Immunotherapy Research & Development (United States), Merck & Co., Inc., Rahway, NJ, USA (United States), GlaxoSmithKline (United Kingdom), Addenbrooke's Hospital, Covance (United States), Great Ormond Street Hospital, AstraZeneca (United Kingdom), University of Pennsylvania, Pfizer (United States), Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Meso Scale Discovery (United States), ADx NeuroSciences
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2152715003